FDA backs away from RFK Jr.’s claims about drug’s promise for autism patients - Politico
AI Summary1 min read
TL;DR
The FDA has clarified that leucovorin, approved for a rare genetic condition, lacks evidence for treating autism, distancing itself from claims by RFK Jr. and the Trump administration.
Tags
FDAautismleucovorindrug approvalRFK Jr.
- FDA backs away from RFK Jr.’s claims about drug’s promise for autism patients Politico
- FDA approves leucovorin for rare genetic condition, but not for autism CNN
- Leucovorin lacks evidence to use as autism treatment, FDA says statnews.com
- FDA approves new use of synthetic vitamin B9 — but not for autism symptoms NBC News
- FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism The Hill